Literature DB >> 5563430

Haemolytic anaemia associated with mefenamic acid.

J H Robertson, C C Kennedy, C M Hill.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1971        PMID： 5563430     DOI： 10.1007/bf02939815

Source DB:  PubMed          Journal:  Ir J Med Sci        ISSN： 0021-1265            Impact factor:   1.568


× No keyword cloud information.
  3 in total

1.  Autoimmune haemolytic anaemia associated with alpha-methyldopa therapy.

Authors:  S M Worlledge; K C Carstairs; J V Dacie
Journal:  Lancet       Date:  1966-07-16       Impact factor: 79.321

2.  Mefanamic acid-induced haemolytic anaemia.

Authors:  J M Jackson; J Quinlan; P Goatcher
Journal:  Br Med J       Date:  1970-05-02

3.  Autoimmune haemolytic anaemia and mefenamic acid therapy.

Authors:  G L Scott; A B Myles; P A Bacon
Journal:  Br Med J       Date:  1968-08-31
  3 in total
  3 in total

Review 1.  Aspirin, paracetamol and non-steroidal anti-inflammatory drugs. A comparative review of side effects.

Authors:  P D Fowler
Journal:  Med Toxicol Adverse Drug Exp       Date:  1987 Sep-Oct

Review 2.  Fatal fulminant autoimmune haemolytic anaemia associated with tolmetin use and gastric carcinoma. Case report and literature review.

Authors:  J R Larsen; J W Becher
Journal:  Drug Saf       Date:  1993-02       Impact factor: 5.606

3.  Is alpha-methyldopa-type autoimmune hemolytic anemia mediated by interferon-gamma?

Authors:  J E Baier; D Poehlau
Journal:  Ann Hematol       Date:  1994-11       Impact factor: 3.673
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.